Current Online Studies

[:de]International TherapieMonitor Multiple Myeloma refractory/relapsed 2018[:en]International TherapieMonitor Multiple Myeloma refractory/relapsed 2018[:]
[:de]National: TherapieMonitor Multiples Myelom 1. Quartal 2019[:en]National: TherapieMonitor Multiples Myelom 1. Quartal 2019[:]
[:de]O.I.s) OncoPanel NSCLC IIIb/IV im 4. Quartal 2018[:en]O.I.s) OncoPanel NSCLC IIIb/IV im 4. Quartal 2018[:]
[:de]O.I.s) OncoPanel Therapie des malignen Melanom im 4. Quartal 2018[:en]O.I.s) OncoPanel Therapie des malignen Melanom im 4. Quartal 2018[:]
[:de]OncoPanel fortgeschrittenes Pankreaskarzinom im 4. Quartal 2018[:en]OncoPanel fortgeschrittenes Pankreaskarzinom im 4. Quartal 2018[:]
[:de]TherapieMonitor ALK+ NSCLC IIIb/IV 2017/2018 [:en]TherapieMonitor ALK+ NSCLC IIIb/IV 2017/2018[:]
[:de]TherapieMonitor HGS Ovarialkarzinom 4. Quartal 2018[:en]TherapieMonitor HGS Ovarialkarzinom 4. Quartal 2018 [:]
[:de]TherapieMonitor Hochgradig Seröses Ovarialkarzinom 2016[:en]TherapieMonitor Hochgradig Seröses Ovarialkarzinom 2016[:]
[:de]TherapieMonitor Malignes Melanom 1. Quartal 2019[:en]TherapieMonitor Malignes Melanom 1. Quartal 2019[:]
[:de]TherapieMonitor Mammakarzinom IV 2017/2018[:en]TherapieMonitor Mammakarzinom IV 2017/2018[:]
[:de]TherapieMonitor MDS, 2. Halbjahr 2018[:en]TherapieMonitor MDS, 2. Halbjahr 2018[:]
[:de]TherapieMonitor NSCLC IIIb-IV 1. Quartal 2019[:en]TherapieMonitor NSCLC IIIb-IV 1. Quartal 2019[:]
[:de]TherapieMonitor Pankreaskarzinom 2017/2018[:en]TM Pankreaskarzinom 2017/2018[:]
[:de]TherapieMonitor Urothelkarzinom Stadium IV 1. Quartal 2019[:en]TherapieMonitor Urothelkarzinom Stadium IV 1. Quartal 2019[:]
[:de]TherapieMonitor Urothelkarzinom Stadium IV, 2. Halbjahr 2017[:en]TherapieMonitor Urothelkarzinom Stadium IV, 2. Halbjahr 2017[:]
[:de]United Kingdom: TherapieMonitor HGS Ovarian Cancer 2016 UK[:en]United Kingdom: TherapieMonitor HGS Ovarian Cancer 2016 UK[:]